Literature DB >> 31006279

The possible role of maternal and placental vitamin D receptor polymorphisms and haplotypes in pathogenesis of preeclampsia.

Farzaneh Farajian-Mashhadi1, Fatemeh Eskandari2,3, Mahnaz Rezaei2,3, Farzaneh Eskandari4, Darya Najafi5, Batool Teimoori6,7, Maryam Moradi-Sharbabak6,7, Saeedeh Salimi2,3.   

Abstract

Purpose: Vitamin D deficiency may be a main causative agent in the pathogenesis of preeclampsia (PE). The actions of the active form of vitamin D are mediated via the vitamin D receptor (VDR), which is expressed in numerous organs including placenta. Therefore, we evaluated the potential relationship between maternal and placental VDR polymorphisms and the predisposition to PE in an Iranian population.
Methods: This case-control study surveyed 152 PE and 160 normotensive pregnant women. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed to examine the maternal and placental VDR Fok1 rs2228570, Bsm1 rs1544410, Taq1 rs731236, and Apa1 rs7975232 polymorphisms.
Results: The maternal but not placental VDR FokI Ff genotype, was significantly lower in PE women (P = .02 and P = .06, respectively). The maternal and placental VDR FokI polymorphism was associated with lower PE risk in the dominant model (Ff+ff vs. FF) and these genotypes could decrease PE risk (OR, 0.5 [95% CI, 0.3-0.8], P = .007 and OR, 0.5 [95% CI, 0.3-0.9], P = .02, respectively). The haplotype analysis revealed that the maternal and placental TABf haplotype may lead to decreased risk of PE. In addition, the placental TABF haplotype was associated with higher risk of PE. No relationship was observed between PE susceptibility and the maternal and placental VDR Bsm1, Taq1 and Apa1 polymorphisms. There was also no relationship between the maternal and placental VDR polymorphisms and PE severity.Conclusions: the maternal and placental VDR FokI variant was associated with decreased risk of PE in the dominant model.

Entities:  

Keywords:  Placenta; haplotype; polymorphism; preeclampsia; vitamin D receptor

Mesh:

Substances:

Year:  2019        PMID: 31006279     DOI: 10.1080/10641963.2019.1601203

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  5 in total

1.  Oxidative stress activated by Keap-1/Nrf2 signaling pathway in pathogenesis of preeclampsia.

Authors:  Hao Feng; Li Wang; Guoxiang Zhang; Zhiwei Zhang; Wei Guo
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

2.  Impaction of factors associated with oxidative stress on the pathogenesis of gestational hypertension and preeclampsia: A Chinese patients based study.

Authors:  Dongmei Qiu; Jufei Wu; Min Li; Li Wang; Xianggan Zhu; Youguo Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

3.  Vitamin D receptor gene polymorphisms and haplotypes in the etiology of recurrent miscarriages.

Authors:  Hubert Wolski; Grażyna Kurzawińska; Marcin Ożarowski; Aleksandra E Mrozikiewicz; Krzysztof Drews; Tomasz M Karpiński; Anna Bogacz; Agnieszka Seremak-Mrozikiewicz
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

4.  Association of AGTR1 (rs5186), VDR (rs2228570) genes polymorphism with blood pressure elevation in patients with essential arterial hypertension.

Authors:  Marianna Mykolaivna Semianiv; Larysa Petrivna Sydorchuk; Valentyna Stepanivna Dzhuryak; Oleg Vasylovich Gerush; Oleg Vasylovich Gerush; Alina Oleksandrivna Palamar; Natalia Yaroslavivna Muzyka; Oksana Mykolaivna Korovenkova; Olesia Mykhaylivna Blazhiievska; Valeriia Valeriivna Sydor; Andrii Ruslanovich Sydorchuk; Igor Oleksandrovich Semianiv; Ruslan Igorovich Sydorchuk
Journal:  J Med Life       Date:  2021 Nov-Dec

5.  Association between vitamin D plasma concentrations and VDR gene variants and the risk of premature birth.

Authors:  Letícia Veríssimo Dutra; Fernando Alves Affonso-Kaufman; Fernanda Ramires Cafeo; Milene Saori Kassai; Caio Parente Barbosa; Francisco Winter Santos Figueiredo; Fabíola Isabel Suano-Souza; Bianca Bianco
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-31       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.